SCHEMBL6957568

SCHEMBL6957568

Cc1nc(N)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.51
ALDH1A1 P00352 7/20 0.51
HPGD P15428 7/20 0.51
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
MAPT P10636 6/20 0.51
HSD17B10 Q99714 4/20 0.51
HTT P42858 3/20 0.51
TP53 P04637 1/20 0.51
ADORA2A P29274 3/20 0.49
RXFP1 Q9HBX9 2/20 0.49
ADRA2A P08913 1/20 0.49
NPSR1 Q6W5P4 2/20 0.44
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.44
MAPKAPK2 P49137 1/20 0.43
MAPK1 P28482 3/20 0.43
PKM P14618 2/20 0.42
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953934 0.84 KDM4E (0.43) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6948665 0.83 KDM4E (0.48) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6952068 0.82 ALDH1A1 (0.49) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6949216 0.81 KDM4E (0.47) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6957783 0.79 HRH4 (0.44) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6950038 0.78 KDM4E (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6951193 0.78 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6956201 0.77 KDM4E (0.41) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6948352 0.77 ALDH1A1 (0.46) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6947782 0.76 CXCR4 (0.41) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed